FDA Approves Selution SLR Drug-Eluting Balloon for Coronary In-Stent Restenosis

Regulatory Approvals — FDA Approves Selution SLR Drug-Eluting Balloon for Coronary In-Stent Restenosis  TCTMD.com

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 21, 2026.

By